Telemedicine

MaNaDr must ensure regulatory compliance regardless of its corporate structure: MOH

2025-04-10T00:48:40.000Z
Investigations into the other five providers are ongoing.

Eight telemed providers, including MaNaDr, investigated for regulatory breaches: Janil

2025-01-07T03:40:10.000Z
A brief look at the MaNaDr app or website reveals little change.
COMMENTARY

With its teleconsultation platform intact, revoking MaNaDr’s licence could have little impact

2024-12-26T10:00:00.000Z
The ministry earlier issued a notice of intent to revoke MaNaDr’s licence on Oct 24.

MaNaDr Clinic loses licence, found to have ‘entrenched culture of disregard’ for ethical and clinical standards: MOH

2024-12-20T09:33:17.000Z
Friday’s circular was issued by the Ministry of Health, the Health Sciences Authority and the Singapore Medical Council.

Clinics warned to get their act together over telehealth, advertising abuses

2024-11-22T09:34:56.000Z
The Singapore Medical Council's Ethical Code and Ethical Guidelines only apply to individual doctors, not telemedicine providers.

Ads by telemedicine providers do not fall under Singapore Medical Council purview

2024-11-14T04:37:52.000Z
The ads for GLP-1 drugs, such as Saxenda, have gained attention for their effectiveness in aiding weight loss.

Singapore authorities now reviewing telemed providers’ ads for weight-loss drugs

2024-11-13T13:09:28.000Z
On Oct 24, MOH announced its intention to revoke MaNaDr’s licence. Minister Ong notes that the regulatory action followed public complaints.

Telemedicine regulations remain valid, no review needed despite MaNaDr case: Ong Ye Kung

2024-11-11T05:20:00.000Z
MaNaDr’s consultations were priced from S$8.20, lower than the typical S$20 to S$25 charged at physical clinics.

MaNaDr’s low prices could have encouraged too-brief teleconsultations: doctors

2024-11-04T11:50:40.000Z
On Oct 24, MOH said it intended to revoke MaNaDr Clinic’s licence.
COMMENTARY

MaNaDr’s exit highlights need for tighter telemedicine audits

2024-10-30T02:06:44.000Z